FundingWatcher
Home / Startups / Top biotech startups / Biotech startups that raised Series B / Biotech startups that raised Series B in Jiangsu, China

Biotech startups that raised Series B in Jiangsu, China

Updated 16 Nov 2026

Reset
Biotech startups that raised Series B in Jiangsu, China
One-time CSV
  • 46 funded companies, 37 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech--series-b~jiangsu-china.csv46 rows × 18 columns
CompanyCityLast roundAmountDate
Yuce BiotechnologySuzhouSeries B$7.4M2026-08-31
HemaCellSuzhouSeries B$14.8M2026-06-02
D3 BioWuxi ShiSeries B$108.0M2025-12-09
CureGeneticsSuzhouSeries B$9.0M2024-03-28
Onechip BioelectronicsZhangjiagangSeries B$13.7M2023-09-28

5 rows of the CSV in 5 of its 18 columns.

46
Startups
$1.6B
Total raised
10
Funded in the last 12 months
$228.4M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

5 of 46
Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
Yuce Biotechnology Yuce Biotechnology focuses on the industrialization of single-molecule immunodiagnostic technologies. Biotech Suzhou Series B $7.4M 2026-08-31 $22.4M Puhua Capital, Zhengxuan Investment, BioTrack Capital +2 101 to 250 2019
HemaCell HemaCell develops cell therapies that regenerate hematopoietic lineages in vitro through stem cell reprogramming. Biotech Suzhou Series B $14.8M 2026-06-02 $62.0M Northern Light Venture Capital, CDH Investments, CMB International Capital Corporation 1 to 10 2021
D3 Bio D3 Bio develops and registers medicines as a biotechnology company. Biotech Wuxi Shi Series B $108.0M 2025-12-09 $370.0M Matrix Partners China, Boyu Capital, Medicxi 1 to 10 2020
CureGenetics CureGenetics develops medicines and molecular diagnostics for cancers and genetic diseases. Biotech Suzhou Series B $9.0M 2024-03-28 Qiming Venture Partners, Oriza Holdings, Qingsong Fund +1 51 to 100 2016
Onechip Bioelectronics Onechip Bioelectronics develops biosensor chips and nanomaterials. Biotech Zhangjiagang Series B $13.7M 2023-09-28 Matrix Partners China, Qiming Venture Partners, Xiamen C&D Emerging Industry Equity Investment +1 11 to 50 2014

Table 1. Biotech startups that raised Series B in Jiangsu, China: the 5 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 46.

Largest rounds

Last 12 months
# Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
1 D3 Bio D3 Bio develops and registers medicines as a biotechnology company. Biotech Wuxi Shi Series B $108.0M 2025-12-09 $370.0M Matrix Partners China, Boyu Capital, Medicxi 1 to 10 2020
2 HemaCell HemaCell develops cell therapies that regenerate hematopoietic lineages in vitro through stem cell reprogramming. Biotech Suzhou Series B $14.8M 2026-06-02 $62.0M Northern Light Venture Capital, CDH Investments, CMB International Capital Corporation 1 to 10 2021
3 Yuce Biotechnology Yuce Biotechnology focuses on the industrialization of single-molecule immunodiagnostic technologies. Biotech Suzhou Series B $7.4M 2026-08-31 $22.4M Puhua Capital, Zhengxuan Investment, BioTrack Capital +2 101 to 250 2019

Table 2. Biotech startups that raised Series B in Jiangsu, China: the 3 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Matrix Partners China Venture capital firm Beijing, China 2 4% 1 D3 Bio
2 Qiming Venture Partners Venture capital firm Shanghai, China 2 4%
3 LH Ventures Private equity firm Shanghai, China 1 2% 1 Yuce Biotechnology
4 BioTrack Capital Venture capital firm Shanghai, China 1 2% 1 Yuce Biotechnology
5 Boyuan Capital Venture capital firm Shanghai, China 1 2% 1 Yuce Biotechnology
6 Zhengxuan Investment Venture capital firm Shenzhen, China 1 2% 1 Yuce Biotechnology
7 Puhua Capital Venture capital firm Hangzhou, China 1 2% 1 Yuce Biotechnology
8 CDH Investments Private equity firm Kowloon City, Hong Kong 1 2% 1 HemaCell
9 Northern Light Venture Capital Venture capital firm Beijing, China 1 2% 1 HemaCell
10 CMB International Capital Corporation Investment bank Central, Hong Kong 1 2% 1 HemaCell
11 Boyu Capital Private equity firm Beijing, China 1 2% 1 D3 Bio
12 Medicxi Venture capital firm London, United Kingdom 1 2% 1 D3 Bio
13 Huatai Zijin Investment Venture capital firm Nanjing, China 1 2% 1 Puguang Bio
14 Advantech Capital Private equity firm Central, Hong Kong 1 2%
15 Qingsong Fund Venture capital firm Shenzhen, China 1 2%

Table 3. Biotech startups that raised Series B in Jiangsu, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 43 93% $1.5B
Hardware 1 2%

Table 4. Biotech startups that raised Series B in Jiangsu, China by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series B 46 100% $28.7M

Table 5. Biotech startups that raised Series B in Jiangsu, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
Suzhou 28 61%
Nanjing 11 24%
Taizhou 2 4%
Nantong 1 2%
Wuxi Shi 1 2%
Zhangjiagang 1 2%
Yangzhou 1 2%
Jiangyin 1 2%

Table 6. Biotech startups that raised Series B in Jiangsu, China by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
August 2026 1 10% $7.4M
June 2026 1 10% $14.8M
May 2026 2 20% $54.7M
January 2026 3 30% $29.2M
December 2025 2 20% $122.3M
November 2025 1 10%

Table 7. Biotech startups that raised Series B in Jiangsu, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 7 15% $106.1M
2025 7 15% $122.3M
2024 4 9% $27.0M
2023 8 17% $238.8M
2022 7 15% $271.8M
2021 3 7% $154.8M

Table 8. Biotech startups that raised Series B in Jiangsu, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2020 to 2022 10 22%
2015 to 2019 21 46%
2010 to 2014 10 22%
Before 2010 5 11%

Table 9. Biotech startups that raised Series B in Jiangsu, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 5 12%
11 to 50 9 22%
51 to 100 8 20%
101 to 250 11 27%
251 to 500 5 12%
501 to 1,000 3 7%

Table 10. Biotech startups that raised Series B in Jiangsu, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in Jiangsu, China whose last round is Series B are on the list?
46, in the file dated 16 November 2026. 10 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 46 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups that raised Series B in Jiangsu, China: 46 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech at other stages in Jiangsu

Other sectors that raised Series B in Jiangsu

Cite: FundingWatcher, 46 biotech companies in Jiangsu, China whose most recent round is Series B, 16 November 2026. https://fundingwatcher.com/startups/biotech/series-b/jiangsu-china/